Timothy Connelly, MD
Internal Medicine · Savannah, GANPI 1467616748
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $31,361 of the $49,861 with a category attached, or 62.9%. Pfizer accounts for 98.8% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $25,883, more than ten times the $324 reported in 2019. Among internal medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $554.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$49K
- Novartis$144
- Merck$75
- E.r. Squibb & Sons, L.L.C.$59
- Lilly USA, LLC$53
- Johnson & Johnson$41
- plus $244 from 11 others
What the payments were for
- Consulting fees$13,22827%
- Speaking & faculty fees$31,36163%
- Travel & lodging$4,2759%
- Food & beverage$9882%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 55 | $49,246 |
| Novartis | 9 | $144 |
| Merck | 4 | $75 |
| E.r. Squibb & Sons, L.L.C. | 4 | $59 |
| Lilly USA, LLC | 3 | $53 |
| Johnson & Johnson | 3 | $41 |
| Novo Nordisk | 2 | $34 |
| Eisai Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Abbott | 1 | $22 |
| Boston Scientific | 1 | $21 |
| Exact Sciences | 1 | $21 |
| Organon | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAXLOVID$45,404
How this compares
$49,861 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 24 | $284 |
| Rosuvastatin Calcium | 16 | $116 |
| Amlodipine Besylate | 24 | $100 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Savannah
- Jennifer WoehlerSavannah$207K
- John DemiccoSavannah$31K
- Paul BradleySavannah$28K
- Wilfredo DolorSavannah$17K
- Thomas HoganSavannah$17K
- Thomas MoriaritySavannah$16K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.